"Our in-vitro and in-vivo experiments show that the RCC1 variants associated with axonal neuropathy in children alter ...

RISING SUN, Ind. (WKRC) — The small town of Rising Sun is rallying around 6-year-old Weston James, who has been diagnosed with Guillain-Barre syndrome, a rare autoimmune disorder that attacks ...

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. | As it advances a ...

A rare Guillain-Barré syndrome recurrence caused nausea with no motor symptoms but was treated successfully with intravenous ...

The FDA is adding a warning about Guillain-Barré syndrome to the respiratory syncytial virus vaccines manufactured by GSK and Pfizer based on data that suggest there may be a link between ...

The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination ...

The European Task Force unveils critical updates on Guillain-Barré syndrome, highlighting new treatment strategies and diagnostic criteria for clinicians. News & Perspective Tools & Reference CME/CE.

The outbreak of Guillain-Barr Syndrome in Pune is a stark reminder of the complexities of autoimmune diseases and their links to infections. While rare, GBS can have life-altering consequences if ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...